Oragenics Inc. OGEN
Key Stats
- Today's Range
- $0.48 – $0.50
- 50-Day Range
- $0.48 – $0.61
- 52-Week Range
- $0.48 – $1.45
- Volume
- 12K shs
- Average Volume
- 32K shs
- Market Cap
- $2.16 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.59
- Price / Sales
- —
Short Interest
- Short Interest
- 6.36%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-10,083,409
- Net Margin
- —
- Return on Equity
- -274.70%
- Debt-to-Equity
- —
About Oragenics Inc.
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
Related Stocks
Compare head-to-head: OGEN vs LLY·OGEN vs JNJ·OGEN vs ABBV·OGEN vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.